Prophylaxis of Migraine Attacks With a Calcium‐Channel Blocker: Flunarizine Versus Methysergide
Authors:
- 10 September 1986
- journal article
- research article
- Published by Wiley in The Journal of Clinical Pharmacology
- Vol. 26 (7) , 524-528
Abstract
In this study, flunarizine, a selective calcium‐channel blocker, was employed in the prophylactic treatment of headache and was compared with methysergide in terms of efficacy. The trial was conducted with 104 patients (53 treated with flunarizine and 51 treated with methysergide) and lasted six months—one month of pretreatment and five months of therapy. Patients in both groups experienced a highly significant reduction in the number and duration of migraine attacks. Unlike those in the methysergide group, patients treated with flunarizine achieved a significant reduction in the intensity of attacks with very negligible side effects.Keywords
This publication has 13 references indexed in Scilit:
- Flunarizine A Review of Its Pharmacodynamic and Pharmacokinetic Properties and Therapeutic UseDrugs, 1984
- The Pharmacology of Calcium Channel Antagonists: a Novel Class of Anti‐migraine Agents?Headache: The Journal of Head and Face Pain, 1983
- Nimodipine, a New Calcium Antagonist, in the Prophylactic Treatment of MigraineHeadache: The Journal of Head and Face Pain, 1983
- Platelet-mediated vascular contractions inhibition by flunarizine, a calcium-entry blockerBiochemical Pharmacology, 1983
- A Double‐blind Placebo‐controlled Prophylactic Study of Flunarizine (Sibelium®) in MigraineHeadache: The Journal of Head and Face Pain, 1981
- HeadacheAnnals of Neurology, 1981
- Pharmacology of MigraineAnnual Review of Pharmacology and Toxicology, 1981
- The Biochemistry of MigraineHeadache: The Journal of Head and Face Pain, 1980
- The Effects of Flunarizine, a New Calcium Antagonist, on Human Red Blood Cells in vitroAngiology, 1980
- The Rheological Effects of Cinnarizine and Flunarizine in Normal and Pathologic ConditionsAngiology, 1979